The main purpose of this legislation is to reverse specific changes made to Medicaid cost-sharing requirements and to the treatment of orphan drugs under the Medicare Drug Price Negotiation Program. The bill aims to restore previous rules that were in place before these changes were enacted. Key provisions of the legislation include the repeal of two specific sections from a prior law. The first provision removes changes that affected how much Medicaid recipients have to pay out of pocket for their healthcare services.